{"schema_version":"1","generated_at":"2026-10-28T08:39:53.211Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/amyn-habib","json_url":"https://www.findmykol.com/kol/amyn-habib/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"amyn-habib","name":"Amyn Habib","credential":"MD","title":"Associate Professor of Neurology and Neurotherapeutics","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology"],"institution":"UT Southwestern Medical Center","institution_url":"https://www.findmykol.com/institution/ut-southwestern-medical-center","city":"Dallas","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1255389003","orcid":"0000-0003-4164-9028","openalex":"A5014124937"},"summary":"Amyn Habib is Associate Professor of Neurology and Neurotherapeutics at UT Southwestern Medical Center. OpenAlex indexes 135 publications with 4,362 citations (h-index 38).","overview":{"text":"Amyn Habib, MD, is Associate Professor of Neurology and Neurotherapeutics at UT Southwestern Medical Center. The public record shows 135 publications with 4,362 citations (h-index 38), centered on Glioma Diagnosis and Treatment, DNA Repair Mechanisms, HER2/EGFR in Cancer Research. It also documents 6 NIH-funded awards (2003–2026).","bullets":["Most recent indexed publication: 2026 · Science translational medicine","Top research focus: Glioma Diagnosis and Treatment"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","DNA Repair Mechanisms","HER2/EGFR in Cancer Research","PARP inhibition in cancer therapy","Effects of Radiation Exposure"]},"scholarship":{"works_count":135,"cited_by_count":4362,"h_index":38,"i10_index":56,"pubmed_count":9,"latest_activity_year":2026,"emerging":true,"source":"works"},"trials":{"count":0,"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"company_count":0,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1255389003","source":"payments"},"funding":{"award_count":6,"fiscal_years":{"first":2003,"last":2026},"rows_total":30,"shown":3,"withheld":27,"rows":[{"project":"R01CA299152","title":"The kinase inhibited RTK forms a scaffold to drive therapeutic resistance in cancer","fiscal_year":2026,"amount_usd":449196,"organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA299152"},{"project":"R01NS119225","title":"Bimodal EGFR signaling in glioblastoma","fiscal_year":2026,"amount_usd":410000,"organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01NS119225"},{"project":"R01CA299152","title":"The kinase inhibited RTK forms a scaffold to drive therapeutic resistance in cancer","fiscal_year":2025,"amount_usd":449196,"organization":"UT SOUTHWESTERN MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R01CA299152"}],"source":"grants"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.","year":2026,"journal":"Science translational medicine","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42418561/","status":"verified"},{"title":"Multifaceted roles of PDS5B in RAD51-dependent homology-directed DNA repair and replication fork protection.","year":2026,"journal":"Nature communications","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42161950/","status":"verified"},{"title":"Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.","year":2024,"journal":"Nature","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39261729/","status":"verified"},{"title":"EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.","year":2022,"journal":"Nature cell biology","types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, U.S. Gov't, Non-P.H.S."],"source_url":"https://pubmed.ncbi.nlm.nih.gov/35915159/","status":"verified"},{"title":"Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids.","year":2021,"journal":"Nature communications","types":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, Non-P.H.S."],"source_url":"https://pubmed.ncbi.nlm.nih.gov/34853306/","status":"verified"}],"most_cited":{"total":135,"shown":5,"withheld":130,"rows":[{"title":"Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance","year":2010,"cited_by_count":471,"type":"article","source_url":"https://doi.org/10.1593/neo.10688"},{"title":"Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis","year":2012,"cited_by_count":264,"type":"article","source_url":"https://doi.org/10.1002/emmm.201201283"},{"title":"An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases","year":2019,"cited_by_count":255,"type":"article","source_url":"https://doi.org/10.1038/s41467-019-13094-5"},{"title":"Ligand-Independent EGFR Signaling","year":2015,"cited_by_count":196,"type":"article","source_url":"https://doi.org/10.1158/0008-5472.can-15-0989"},{"title":"Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma","year":2013,"cited_by_count":171,"type":"article","source_url":"https://doi.org/10.1158/1078-0432.ccr-13-1607"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Sandeep Burma","coauthored_works":72},{"name":"Kimmo J. Hatanpaa","coauthored_works":39},{"name":"Dawen Zhao","coauthored_works":31}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/amyn-habib-md","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://contactout.com/amyn-habib-48241","status":"provisional","collected_at":"2026-10-26"}]}},"similar":[{"name":"Madhukar Trivedi","slug":"madhukar-trivedi","institution":"UT Southwestern Medical Center","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/madhukar-trivedi","json_url":"https://www.findmykol.com/kol/madhukar-trivedi/profile.json"},{"name":"Ildiko Lingvay","slug":"ildiko-lingvay","institution":"UT Southwestern Medical Center","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/ildiko-lingvay","json_url":"https://www.findmykol.com/kol/ildiko-lingvay/profile.json"},{"name":"Ambarish Pandey","slug":"ambarish-pandey","institution":"UT Southwestern Medical Center","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/ambarish-pandey","json_url":"https://www.findmykol.com/kol/ambarish-pandey/profile.json"},{"name":"Olaf Stuve","slug":"olaf-stuve","institution":"UT Southwestern Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/olaf-stuve","json_url":"https://www.findmykol.com/kol/olaf-stuve/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":27,"publications":4,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-26"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}